Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'I-123 BETA-CIT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 128 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Thobois, S; Guillouet, S; Broussolle, E
      Contributions of PET and SPECT to the understanding of the pathophysiologyof Parkinson's disease

      NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    2. Fowler, JS; Volkow, ND; Wang, GJ; Gatley, SJ; Logan, J
      [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy

      NUCLEAR MEDICINE AND BIOLOGY
    3. Carpinelli, A; Matarrese, M; Moresco, RM; Simonelli, P; Todde, S; Magni, F; Kienle, MG; Fazio, F
      Radiosynthesis of [I-123]beta CIT, a selective ligand for the study of thedopaminergic and serotoninergic systems in human brain

      APPLIED RADIATION AND ISOTOPES
    4. Verhoeff, NPLG
      Imaging of dopaminergic transmission in neuropsychiatric disorders

      CURRENT OPINION IN PSYCHIATRY
    5. Stamenkovic, M; Schindler, SD; Asenbaum, S; Neumeister, A; Willeit, M; Willinger, U; de Zwaan, M; Riederer, F; Aschauer, HN; Kasper, S
      No change in striatal dopamine re-uptake site density in psychotropic drugnaive and in currently treated Tourette's disorder patients: a [I-123]-beta-CIT SPECT-study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    6. Bergstrom, KA; Tupala, E; Tiihonen, J
      Dopamine transporter in vitro binding and in vivo imaging in the brain

      PHARMACOLOGY & TOXICOLOGY
    7. Murai, T; Muller, U; Werheid, K; Sorger, D; Reuter, M; Becker, T; von Cramon, DY; Barthel, H
      In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    8. Martinez, D; Gelernter, J; Abi-Dargham, A; van Dyck, CH; Kegeles, L; Innis, RB; Laruelle, M
      The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporterphenotype in humans

      NEUROPSYCHOPHARMACOLOGY
    9. Staley, JK; Krishnan-Sarin, S; Zoghbi, S; Tamagnan, G; Fujita, M; Seibyl, JP; Maciejewski, PK; O'Malley, S; Innis, RB
      Sex differences in [I-123]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

      SYNAPSE
    10. Fischman, AJ; Bonab, AA; Babich, JW; Livni, E; Alpert, NM; Meltzer, PC; Madras, BK
      [C-11,I-127] altropane: A highly selective ligand for PET imaging of dopamine transporter sites

      SYNAPSE
    11. Booij, J; Bergmans, P; Winogrodzka, A; Speelman, JD; Wolters, EC
      Imaging of dopamine transporters with [I-123]FP-CIT SPECT does not suggesta significant effect of age on the symptomatic threshold of disease in Parkinson's disease

      SYNAPSE
    12. Varrone, A; Marek, KL; Jennings, D; Innis, RB; Seibyl, JP
      [I-123]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

      MOVEMENT DISORDERS
    13. Winogrodzka, A; Wagenaar, RC; Bergmans, P; Vellinga, A; Booij, J; van Royen, EA; van Emmerik, REA; Stoof, JC; Wolters, EC
      Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients

      MOVEMENT DISORDERS
    14. Haapaniemi, TH; Ahonen, A; Torniainen, P; Sotaniemi, KA; Myllyla, VV
      [I-123]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients

      MOVEMENT DISORDERS
    15. Berendse, HW; Booij, J; Francot, CMJE; Bergmans, PLM; Hijman, R; Stoof, JC; Wolters, EC
      Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

      ANNALS OF NEUROLOGY
    16. Kuikka, JT; Tammela, L; Bergstrom, KA; Karhunen, L; Uusitupa, M; Tiihonen, J
      Effects of ageing on serotonin transporters in healthy females

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    17. Booij, J; Speelman, JD; Horstink, MWIM; Wolters, EC
      The clinical benefit of imaging striatal dopamine transporters with [I-123]FP-CIT SPET in differentiating patients with presynaptic parkinsonism fromthose with other forms of parkinsonism

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    18. Barthel, H; Sorger, D; Kuhn, HJ; Wagner, A; Kluge, R; Hermann, W
      Differential alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [I-123]beta-CIT and high-resolution SPET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    19. Winogrodzka, A; Bergmans, P; Booij, J; van Royen, EA; Janssen, AGM; Wolters, EC
      [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    20. Miller, GM; Yatin, SM; De La Garza, R; Goulet, M; Madras, BK
      Cloning of dopamine, norepinephrine and serotonin transporters from monkeybrain: relevance to cocaine sensitivity

      MOLECULAR BRAIN RESEARCH
    21. Tatsch, K
      Imaging of the dopaminergic system in parkinsonism with SPET

      NUCLEAR MEDICINE COMMUNICATIONS
    22. Neumeister, A; Willeit, M; Praschak-Rieder, N; Asenbaum, S; Stastny, J; Hilger, E; Pirker, W; Konstantinidis, A; Kasper, S
      Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls

      PSYCHOLOGICAL MEDICINE
    23. Marek, K; Innis, R; van Dyck, C; Fussell, B; Early, M; Eberly, S; Oakes, D; Seibyl, J
      [I-123]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

      NEUROLOGY
    24. Guttman, M; Stewart, D; Hussey, D; Wilson, A; Houle, S; Kish, S
      Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD

      NEUROLOGY
    25. Sakakibara, R; Shinotoh, H; Uchiyama, T; Yoshiyama, M; Hattori, T; Yamanishi, T
      SPECT imaging of the dopamine transporter with [I-123]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    26. Willeit, M; Stastny, J; Pirker, W; Praschak-Rieder, N; Neumeister, A; Asenbaum, S; Tauscher, J; Fuchs, K; Sieghart, W; Hornik, K; Aschauer, HN; Brucke, T; Kasper, S
      No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism

      BIOLOGICAL PSYCHIATRY
    27. Tauscher, J; Pirker, W; Willeit, M; de Zwaan, M; Bailer, U; Neumeister, A; Asenbaum, S; Lennkh, C; Praschak-Rieder, N; Brucke, T; Kasper, S
      [I-123] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

      BIOLOGICAL PSYCHIATRY
    28. Laakso, A; Hietala, J
      PET studies of brain monoamine transporters

      CURRENT PHARMACEUTICAL DESIGN
    29. Dahlstrom, M; Ahonen, A; Ebeling, H; Torniainen, P; Heikkila, J; Moilanen, I
      Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents

      MOLECULAR PSYCHIATRY
    30. Hristova, AH; Koller, WC
      Early Parkinson's disease - What is the best approach to treatment

      DRUGS & AGING
    31. Heinz, A; Jones, DW; Raedler, T; Coppola, R; Knable, MB; Weinberger, DR
      Neuropharmacological studies with SPECT in neuropsychiatric disorders

      NUCLEAR MEDICINE AND BIOLOGY
    32. Shinotoh, H; Uchida, Y; Ito, H; Hattori, T
      Relationship between striatal [I-123]beta-CIT binding and four major clinical signs in Parkinson's disease

      ANNALS OF NUCLEAR MEDICINE
    33. Pirker, W; Asenbaum, S; Bencsits, G; Prayer, D; Gerschlager, W; Deecke, L; Brucke, T
      [I-123]beta-CIT SPECT in multiple system atrophy, progressive supranuclearpalsy, and corticobasal degeneration

      MOVEMENT DISORDERS
    34. Wyper, D; Patterson, J
      The utility of neuroSPECT imaging in the investigation of dementia and parkinsonism

      IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE
    35. Lavalaye, J; Knol, RJJ; de Bruin, K; Reneman, L; Janssen, AGM; Booij, J
      [I-123]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    36. Muller-Vahl, KR; Berding, G; Brucke, T; Kolbe, H; Meyer, GJ; Hundeshagen, H; Dengler, R; Knapp, WH; Emrich, HM
      Dopamine transporter binding in Gilles de la Tourette syndrome

      JOURNAL OF NEUROLOGY
    37. Brucke, T; Djamshidian, S; Bencsits, G; Pirker, W; Asenbaum, S; Podreka, I
      SPECT and PET imaging of the dopaminergic system in Parkinson's disease

      JOURNAL OF NEUROLOGY
    38. Wolters, EC; Francot, C; Bergmans, P; Winogrodzka, A; Booij, J; Berendse, HW; Stoof, JC
      Preclinical (premotor) Parkinson's disease

      JOURNAL OF NEUROLOGY
    39. Fall, PA; Ekberg, S; Granerus, AK; Granerus, G
      ECT in Parkinson's disease - dopamine transporter visualised by [I-123]-beta-CIT SPECT

      JOURNAL OF NEURAL TRANSMISSION
    40. Staffen, W; Mair, A; Unterrainer, J; Trinka, E; Ladurner, G
      Measuring the progression of idiopathic Parkinson's disease with [I-123] beta-CIT SPECT

      JOURNAL OF NEURAL TRANSMISSION
    41. Muller, U; Wachter, T; Barthel, H; Reuter, M; von Cramon, DY
      Striatal [I-123]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    42. Nurmi, E; Bergman, J; Eskola, O; Solin, O; Hinkka, SM; Sonninen, P; Rinne, JO
      Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    43. van Dyck, CH; Malison, RT; Seibyl, JP; Laruelle, M; Klumpp, H; Zoghbi, SS; Baldwin, RM; Innis, RB
      Age-related decline in central serotonin transporter availability with [I-123]beta-CIT SPECT

      NEUROBIOLOGY OF AGING
    44. Heinz, A; Goldman, D
      Genotype effects on neurodegeneration and neuroadaptation in monoaminergicneurotransmitter systems

      NEUROCHEMISTRY INTERNATIONAL
    45. Bonab, AA; Fischman, AJ; Alpert, NM
      Comparison of 4 methods for quantification of dopamine transporters by SPECT with [I-123]IACFT

      JOURNAL OF NUCLEAR MEDICINE
    46. Pirker, W; Asenbaum, S; Hauk, M; Kandlhofer, S; Tauscher, J; Willeit, M; Neumeister, A; Praschak-Rieder, N; Angelberger, P; Brucke, T
      Imaging serotonin and dopamine transporters with I-123-beta-CIT SPECT: Binding kinetics and effects of normal aging

      JOURNAL OF NUCLEAR MEDICINE
    47. Simon, O
      Place of the paraclinical exams in the Parkinson's disease: review.

      REVUE NEUROLOGIQUE
    48. Hermann, W; Barthel, H; Reuter, M; Georgi, P; Dietrich, J; Wagner, A
      Constellation of findings on nigrostriatal system in case of Hallervorden-Spatz Disease

      NERVENARZT
    49. Kim, GM; Kim, SE; Lee, WY
      Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: Studied with [I-123]beta-CIT and SPECT

      EUROPEAN NEUROLOGY
    50. Willeit, M; Praschak-Rieder, N; Neumeister, A; Pirker, W; Asenbaum, S; Vitouch, O; Tauscher, J; Hilger, E; Stastny, J; Brucke, T; Kasper, S
      [I-123]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

      BIOLOGICAL PSYCHIATRY
    51. Laruelle, M; Abi-Dargham, A; van Dyck, C; Gil, R; D'Souza, DC; Krystal, J; Seibyl, J; Baldwin, R; Innis, R
      Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [I-123]beta-CIT

      BIOLOGICAL PSYCHIATRY
    52. Jacobsen, LK; Staley, JK; Malison, RT; Zoghbi, SS; Seibyl, JP; Kosten, TR; Innis, RB
      Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients

      AMERICAN JOURNAL OF PSYCHIATRY
    53. Jacobsen, LK; Staley, JK; Zoghbi, S; Seibyl, JP; Kosten, TR; Innis, RB; Gelernter, J
      Prediction of dopamine transporter binding availability by genotype: A preliminary report

      AMERICAN JOURNAL OF PSYCHIATRY
    54. Bartenstein, P; Grunwald, F; Kuwert, T; Tatsch, K; Sabri, O; Benkert, O; Fahlbusch, R; Grunder, G; Herzholz, K; Weiller, C
      Clinical applications of single photon emission tomography in neuromedicine Part 1: Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease

      NUKLEARMEDIZIN-NUCLEAR MEDICINE
    55. Tauscher, J; Pirker, W; de Zwaan, M; Asenbaum, S; Brucke, T; Kasper, S
      In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    56. Ahlskog, JE; Uitti, RJ; O'Connor, MK; Maraganore, DM; Matsumoto, JY; Stark, KF; Turk, MF; Burnett, OL
      The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

      MOVEMENT DISORDERS
    57. Innis, RB; Marek, KL; Sheff, K; Zoghbi, S; Castronuovo, J; Feigin, A; Seibyl, JP
      Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [I-123]beta-CIT

      MOVEMENT DISORDERS
    58. Helfenbein, J; Emond, P; Loc'h, C; Bottlaender, M; Ottaviani, M; Guilloteau, D; Maziere, B; Frangin, Y; Chalon, S
      Synthesis of (E)-N-(3-bromoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(4 '-tolyl) nortropane (PE2Br) and radiolabelling of [Br-76]PE2Br: A potential ligand for exploration of the dopamine transporter by PET.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    59. Acton, PD; Kung, MP; Mu, M; Plossl, K; Hou, C; Siciliano, M; Oya, S; Kung, HF
      Single-photon emission tomography imaging of serotonin transporters in thenon-human primate brain with the selective radioligand [I-123]IDAM

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    60. Booij, J; Tissingh, G; Winogrodzka, A; van Royen, EA
      Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    61. Acton, PD; Mozley, PD; Kung, HF
      Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    62. Heinz, A
      Neurobiological and anthropological aspects of compulsions and rituals

      PHARMACOPSYCHIATRY
    63. Kim, SE; Lee, WY; Choe, YS; Kim, JH
      SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonintransporters in Parkinson's disease: Correlation with symptom severity

      NEUROLOGICAL RESEARCH
    64. Habraken, JBA; Booij, J; Slomka, P; Sokole, EB; van Royen, EA
      Quantification and visualization of defects of the functional dopaminergicsystem using an automatic algorithm

      JOURNAL OF NUCLEAR MEDICINE
    65. Booij, J; Hemelaar, JTGM; Speelman, JD; de Bruin, K; Janssen, AGM; van Royen, EA
      One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [I-123]FPCIT SPECT

      JOURNAL OF NUCLEAR MEDICINE
    66. Ichise, M; Kim, YJ; Erami, SS; Ballinger, JR; Vines, D; Tanaka, F; Lang, AE
      Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of I-123-beta-CIT SPECT data

      JOURNAL OF NUCLEAR MEDICINE
    67. Ichise, M; Kim, YJ; Ballinger, JR; Vines, D; Erami, SS; Tanaka, F; Lang, AE
      SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD

      NEUROLOGY
    68. Helfenbein, J; Loc'h, C; Bottlaender, M; Emond, P; Coulon, C; Ottaviani, M; Fuseau, C; Chalon, S; Guenther, I; Besnard, JC; Frangin, Y; Guilloteau, D; Maziere, B
      A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments

      LIFE SCIENCES
    69. Stoof, JC; Winogrodzka, A; van Muiswinkel, FL; Wolters, EC; Voorn, P; Groenewegen, HJ; Booij, J; Drukarch, B
      Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy

      EUROPEAN JOURNAL OF PHARMACOLOGY
    70. Semple, DM; Ebmeier, KP; Glabus, MF; O'Carroll, RE; Johnstone, EC
      Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

      BRITISH JOURNAL OF PSYCHIATRY
    71. Eberling, JL; Bankiewicz, KS; Pivirotto, P; Bringas, J; Chen, K; Nowotnik, DP; Steiner, JP; Budinger, TF; Jagust, WJ
      Dopamine transporter loss and clinical changes in MPTP-lesioned primates

      BRAIN RESEARCH
    72. Piggott, MA; Marshall, EF; Thomas, N; Lloyd, S; Court, JA; Jaros, E; Burn, D; Johnson, M; Perry, RH; McKeith, IG; Ballard, C; Perry, EK
      Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution

      BRAIN
    73. Verhoeff, NPLG
      Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders

      PSYCHOPHARMACOLOGY
    74. GUILLOTEAU D; EMOND P; BAULIEU JL; GARREAU L; FRANGIN Y; POURCELOT L; MAUCLAIRE L; BESNARD JC; CHALON S
      EXPLORATION OF THE DOPAMINE TRANSPORTER - IN-VITRO AND IN-VIVO CHARACTERIZATION OF A HIGH-AFFINITY AND HIGH-SPECIFICITY IODINATED TROPANE DERIVATIVE TA-CARBOMETHOXY-3-BETA-(4'-METHYLPHENYL)NORTROPANE (PE2I)

      Nuclear medicine and biology
    75. FISCHMAN AJ; BONAB AA; BABICH JW; PALMER EP; ALPERT NM; ELMALEH DR; CALLAHAN RJ; BARROW SA; GRAHAM W; MELTZER PC; HANSON RN; MADRAS BK
      RAPID DETECTION OF PARKINSONS-DISEASE BY SPECT WITH ALTROPANE - A SELECTIVE LIGAND FOR DOPAMINE TRANSPORTERS

      Synapse
    76. SCHEFFEL U; SZABO Z; MATHEWS WB; FINLEY PA; DANNALS RF; RAVERT HT; SZABO K; YUAN J; RICAURTE GA
      IN-VIVO DETECTION OF SHORT-TERM AND LONG-TERM MDMA NEUROTOXICITY - A POSITRON-EMISSION-TOMOGRAPHY STUDY IN THE LIVING BABOON BRAIN

      Synapse
    77. FOWLER JS; VOLKOW ND; LOGAN J; GATLEY SJ; PAPPAS N; KING P; DING YS; WANG GJ
      MEASURING DOPAMINE TRANSPORTER OCCUPANCY BY COCAINE IN-VIVO - RADIOTRACER CONSIDERATIONS

      Synapse
    78. WENNING GK; DONNEMILLER E; GRANATA R; RICCABONA G; POEWE W
      I-123 BETA-CIT AND I-123 IBZM-SPECT SCANNING IN LEVODOPA-NAIVE PARKINSONS-DISEASE

      Movement disorders
    79. BOOIJ J; SOKOLE EB; STABIN MG; JANSSEN AGM; DEBRUIN K; VANROYEN EA
      HUMAN BIODISTRIBUTION AND DOSIMETRY OF [I-123] FP-CIT - A POTENT RADIOLIGAND FOR IMAGING OF DOPAMINE TRANSPORTERS

      European journal of nuclear medicine
    80. DRESEL SHJ; KUNG MP; PLOSSL K; MEEGALLA SK; KUNG HF
      PHARMACOLOGICAL EFFECTS OF DOPAMINERGIC DRUGS ON IN-VIVO BINDING OF [TC-99M]TRODAT-1 TO THE CENTRAL DOPAMINE TRANSPORTERS IN RATS

      European journal of nuclear medicine
    81. MULLER T; KUHN W; BUTTNER T; EISING E; COENEN H; HAAS M; PRZUNTEK H
      COLOR-VISION ABNORMALITIES DO NOT CORRELATE WITH DOPAMINERGIC NIGROSTRIATAL DEGENERATION IN PARKINSONS-DISEASE

      Journal of neurology
    82. TISSINGH G; BERGMANS P; BOOIJ J; WINOGRODZKA A; VANROYEN EA; STOOF JC; WOLTERS EC
      DRUG-NAIVE PATIENTS WITH PARKINSONS-DISEASE IN HOEHN AND YAHR STAGE-IAND STAGE-II SHOW A BILATERAL DECREASE IN STRIATAL DOPAMINE TRANSPORTERS AS REVEALED BY [I-123] BETA-CIT SPECT

      Journal of neurology
    83. Asenbaum, S; Pirker, W; Angelberger, P; Bencsits, G; Pruckmayer, M; Brucke, T
      [I-123]beta-CIT and SPECT in essential tremor and Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    84. SEIBYL JP; MAREK K; SHEFF K; ZOGHBI S; BALDWIN RM; CHARNEY DS; VANDYCK CH; INNIS RB
      IODINE-123-BETA-CIT AND IODINE-123-FPCIT SPECT MEASUREMENT OF DOPAMINE TRANSPORTERS IN HEALTHY-SUBJECTS AND PARKINSONS PATIENTS

      The Journal of nuclear medicine
    85. TISSINGH G; BOOIJ J; BERGMANS P; WINOGRODZKA A; JANSSEN AGM; VANROYEN EA; STOOF JC; WOLTERS EC
      L-2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SPECT IN HEALTHY CONTROLS AND EARLY-STAGE, DRUG-NAIVE PARKINSONS-DISEASE

      The Journal of nuclear medicine
    86. BOOIJ J; HABRAKEN JBA; BERGMANS P; TISSINGH G; WINOGRODZKA A; WOLTERS EC; JANSSEN AGM; STOOF JC; VANROYEN EA
      IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-FP-CIT SPECT IN HEALTHY CONTROLS AND PATIENTS WITH PARKINSONS-DISEASE

      The Journal of nuclear medicine
    87. HEINZ A; KNABLE MB; WOLF SS; JONES DW; GOREY JG; HYDE TM; WEINBERGER DR
      TOURETTES-SYNDROME - [I-123] BETA-CIT SPECT CORRELATES OF VOCAL TIC SEVERITY

      Neurology
    88. MULLER T; FARAHATI J; KUHN W; EISING EG; PRZUNTEK H; REINERS C; COENEN HH
      [I-123] BETA-CIT SPECT VISUALIZES DOPAMINE TRANSPORTER LOSS IN DE-NOVO PARKINSONIAN-PATIENTS

      European neurology
    89. MALISON RT; PRICE LH; BERMAN R; VANDYCK CH; PELTON GH; CARPENTER L; SANACORA G; OWENS MJ; NEMEROFF CB; RAJEEVAN N; BALDWIN RM; SEIBYL JP; INNIS RB; CHARNEY DS
      REDUCED BRAIN-SEROTONIN TRANSPORTER AVAILABILITY IN MAJOR DEPRESSION AS MEASURED BY [I-123] 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE AND SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY

      Biological psychiatry
    90. HEINZ A; HIGLEY JD; GOREY JG; SAUNDERS RC; JONES DW; HOMMER D; ZAJICEK K; SUOMI SJ; LESCH KP; WEINBERGER DR; LINNOILA M
      IN-VIVO ASSOCIATION BETWEEN ALCOHOL-INTOXICATION, AGGRESSION, AND SEROTONIN TRANSPORTER AVAILABILITY IN NONHUMAN-PRIMATES

      The American journal of psychiatry
    91. HEINZ A; RAGAN P; JONES DW; HOMMER D; WILLIAMS W; KNABLE MB; GOREY JG; DOTY L; GEYER C; LEE KS; COPPOLA R; WEINBERGER DR; LINNOILA M
      REDUCED CENTRAL SEROTONIN TRANSPORTERS IN ALCOHOLISM

      The American journal of psychiatry
    92. MALISON RT; MCCANCE E; CARPENTER LL; BALDWIN RM; SEIBYL JP; PRICE LH; KOSTEN TR; INNIS RB
      [I-123] BETA-CIT SPECT IMAGING OF DOPAMINE TRANSPORTER AVAILABILITY AFTER MAZINDOL ADMINISTRATION IN HUMAN COCAINE ADDICTS

      Psychopharmacology
    93. EISING EG; MULLER TT; ZANDER C; KUHN W; FARAHATI J; REINERS C; COENEN HH
      SPECT-EVALUATION OF THE MONOAMINE UPTAKE SITE LIGAND [I-123] -2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)-TROPANE ([I-123]BETA-CIT) IN UNTREATED PATIENTS WITH SUSPICION OF PARKINSON-DISEASE

      Journal of investigative medicine
    94. LOGAN J; VOLKOW ND; FOWLER JS; WANG GJ; FISCHMAN MW; FOLTIN RW; ABUMRAD NN; VITKUN S; GATLEY SJ; PAPPAS N; HITZEMANN R; SHEA CE
      CONCENTRATION AND OCCUPANCY OF DOPAMINE TRANSPORTERS IN COCAINE ABUSERS WITH [C-11] COCAINE AND PET

      Synapse
    95. BOOIJ J; ANDRINGA G; RIJKS LJM; VERMEULEN RJ; DEBRUIN K; BOER GJ; JANSSEN AGM; VANROYEN EA
      [I-123] FP-CIT BINDS TO THE DOPAMINE TRANSPORTER AS ASSESSED BY BIODISTRIBUTION STUDIES IN RATS AND SPECT STUDIES IN MPTP-LESIONED MONKEYS

      Synapse
    96. MORGAN AE; PORTER SP; CLARKSON FA; VOLKOW ND; FOWLER JS; DEWEY SL
      DIRECT APPROACH FOR ATTENUATING COCAINE EFFECTS ON EXTRACELLULAR DOPAMINE - TARGETING THE DOPAMINE TRANSPORTER

      Synapse
    97. FUJITA M; TAKATOKU K; MATOBA Y; NISHIURA M; KOBAYASHI K; INOUE O; NISHIMURA T
      ENHANCEMENT OF [I-123] BETA-CIT BINDING IN THE STRIATUM WITH CLOMIPRAMINE - IS THERE A SEROTONIN-DOPAMINE INTERACTION

      European journal of nuclear medicine
    98. TATSCH K; SCHWARZ J; MOZLEY PD; LINKE R; POGARELL O; OERTEL WH; FIEBER RS; HAHN K; KUNG HF
      RELATIONSHIP BETWEEN CLINICAL-FEATURES OF PARKINSONS-DISEASE AND PRESYNAPTIC DOPAMINE TRANSPORTER BINDING ASSESSED WITH [I-123] IPT AND SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    99. DONNEMILLER E; HEILMANN J; WENNING GK; BERGER W; DECRISTOFORO C; MONCAYO R; POEWE W; RANSMAYR G
      BRAIN PERFUSION SCINTIGRAPHY WITH TC-99M-HMPAO OR TC-99M-ECD AND I-123 BETA-CIT SINGLE-PHOTON EMISSION TOMOGRAPHY IN DEMENTIA OF THE ALZHEIMER-TYPE AND DIFFUSE LEWY BODY DISEASE

      European journal of nuclear medicine
    100. TIIHONEN J; KUIKKA JT; BERGSTROM KA; KARHU J; VIINAMAKI H; LEHTONEN J; HALLIKAINEN T; YANG JW; HAKOLA P
      SINGLE-PHOTON EMISSION TOMOGRAPHY IMAGING OF MONOAMINE TRANSPORTERS IN IMPULSIVE VIOLENT BEHAVIOR

      European journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 10:03:06